Response of Unvaccinated US Adults to Official Information About the Pause in Use of the Johnson & Johnson-Janssen COVID-19 Vaccine
Mishra, V.; Dexter, J. P.
Show abstract
On April 13, 2021 the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) recommended in a pause in use of the Johnson & Johnson (J&J)-Janssen COVID-19 vaccine due to reports of cerebral venous sinus thrombosis (CVST) in recently vaccinated individuals. The announcement of the pause required development of a coordinated communication strategy under extreme time pressure and careful messaging by stakeholders to mitigate reduced public confidence in COVID-19 vaccines, as was observed following the temporary suspension of the Oxford-AstraZeneca vaccine in many countries. In this survey study, we evaluated understanding and impressions of the CDCs public online information about the J&J-Janssen pause among unvaccinated US adults.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Self-Reported SARS-CoV-2 Vaccination is Consistent with Electronic Health Record Data among the COVID-19 Community Research Partnership 95%
- Race-ethnicity and Perceptional Determinants of COVID-19 Vaccination Intentions: A Cross-sectional Study Among Health Workers and the General Population in the San Francisco Bay Area 94%
- Predictors of COVID-19 Vaccine Hesitancy: Socio-demographics, Co-Morbidity and Past Experience of Racial Discrimination 94%
Similar papers in this journal
- Poor Readability of COVID-19 Vaccine Information for the General Public: A Lost Opportunity 93%
- 2024-2025 BNT162b2 COVID-19 vaccine effectiveness in non-immunocompromised adults: mid-season estimates from vaccine registries in two states linked to administrative claims 93%
- The impact of side effect framing on COVID-19 booster vaccine intentions in an Australian sample 93%
Similar papers in this journal
- Factors indicating intention to vaccinate with a COVID-19 vaccine among older U.S. Adults 96%
- COVID-19 Vaccine Hesitancy in Underserved Communities of North Carolina 95%
- Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy in a massive online survey of US adults: January-May 2021 95%
Similar papers in this journal
- Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials 93%
- Safety of the BNT162b2 mRNA COVID-19 Vaccine in Children below 5 Years (CoVacU5) – an Investigator-Initiated Retrospective Cohort Study 92%
- Epidemiology of myocarditis and pericarditis following mRNA vaccines in Ontario, Canada: by vaccine product, schedule and interval 92%
Similar papers in this journal
- COVID-19 vaccine hesitancy January-March 2021 among 18-64 year old US adults by employment and occupation 94%
- Associations of Race/Ethnicity and Other Demographic and Socioeconomic Factors with Vaccine Initiation and Intention During the COVID-19 Pandemic in the United States 94%
- COVID-19 booster vaccine attitudes and behaviors among university students and staff: the USC Trojan Pandemic Research Initiative 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.